TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24549598

Group type: EXPERIMENTAL
Intervention: Leukocyte PIK3CD mRNA expression in GDM
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Leukocyte PIK3CD mRNA expression
Number of subjects: 175
Study: 21562918

Group type: EXPERIMENTAL
Intervention: Modified two-port VATS procedure (group A)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Axillary minithoracotomy (group B)
Number of subjects: 66
Study: 20717085

Group type: EXPERIMENTAL
Intervention: Direct machine parameter optimization (DMPO) plan
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fluence only (FO) plan
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cumulative dose evaluation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Average fractional dose
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CTV-to-PTV margins
Number of subjects: 30
Study: 17713804

Group type: EXPERIMENTAL
Intervention: DHASCO-T capsules at doses of 200 mg DHA per day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DHASCO-T capsules at doses of 600 mg DHA per day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DHASCO-T capsules at doses of 1,000 mg DHA per day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DHASCO-S capsules at doses of 200 mg DHA per day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DHASCO-S capsules at doses of 600 mg DHA per day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DHASCO-S capsules at doses of 1,000 mg DHA per day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Algal-DHA-fortified food
Number of subjects: 36
Study: 15842464

Group type: EXPERIMENTAL
Intervention: Oral UFT
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bolus IV 5-FU
Number of subjects: 20
Study: 12061758

Group type: EXPERIMENTAL
Intervention: Mental simulation of lifting a heavy object
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Frequency of simulation exercises
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Amount of weight simulated lifting
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Mental simulations manipulated within subjects
Number of subjects: 5
Study: 9657469

Group type: EXPERIMENTAL
Intervention: Primary stenting
Number of subjects: 227

Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 227
Study: 7808848

Group type: EXPERIMENTAL
Intervention: 20 micrograms subunit vaccine
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 50 micrograms subunit vaccine
Number of subjects: 33

Group type: COMPARATOR
Intervention: Saline placebo control
Number of subjects: 33
Study: 2766267

Group type: EXPERIMENTAL
Intervention: Psychoeducational preparation 1‐2 days prior to surgery
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no psychoeducational preparation)
Number of subjects: 30
Study: 1130885

Group type: EXPERIMENTAL
Intervention: Clindamycin or Cephalothin (antibiotic therapy randomized, given intravenously prior to operation and for 5 days thereafter)
Number of subjects: 512
Study: 31918232

Group type: EXPERIMENTAL
Intervention: Single‐ or mixed‐gender group therapy (for women)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Mixed‐gender group therapy (for men)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Perceived stress and substance use levels
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Perceived stress (controlling for substance use)
Number of subjects: 158
Study: 31272977

Group type: EXPERIMENTAL
Intervention: AppSalt intervention group
Number of subjects: 1782

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1782
Study: 29018064

Group type: EXPERIMENTAL
Intervention: Melanoma Care Intervention (psychoeducational booklet, Cancer Council booklet, up to five telephone-based sessions with a psychologist)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual care (Cancer Council booklet only)
Number of subjects: 24
Study: 26202996

Group type: EXPERIMENTAL
Intervention: Immediate treatment (cognitive-behavioral therapy)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 151
Study: 23975656

Group type: EXPERIMENTAL
Intervention: Golimumab 50 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Golimumab 100 mg
Number of subjects: 24
Study: 21447531

Group type: EXPERIMENTAL
Intervention: Topical application of gelatin microspheres prepared with basic fibroblast growth factor (b‐FGF)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard treatment without any topical treatment
Number of subjects: 42
Study: 19327625

Group type: EXPERIMENTAL
Intervention: Home-based nurse care (HBNC) for 12 months
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Home-based nurse care (HBNC) for 12 months in patients with supramedian BNP
Number of subjects: 96

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 96
Study: 16892912

Group type: COMPARATOR
Intervention: Vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequential and multistage designs
Number of subjects: 0
Study: 15306668

Group type: EXPERIMENTAL
Intervention: Venom immunotherapy
Number of subjects: 1033

Group type: COMPARATOR
Intervention: No venom immunotherapy
Number of subjects: 1033
Study: 11879271

Group type: EXPERIMENTAL
Intervention: Increased education for rural providers using clinical opinion leaders
Number of subjects: 0
Study: 9251637

Group type: EXPERIMENTAL
Intervention: English-language articles reporting significant results (p < 0.05)
Number of subjects: 40

Group type: COMPARATOR
Intervention: German-language articles reporting significant results (p < 0.05)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall comparison of significant results between English and German articles
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Publication odds for trials with significant results in English
Number of subjects: 40
Study: 8505011

Group type: EXPERIMENTAL
Intervention: Nasal spray (11 mg natural progesterone)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intramuscular injection (11 mg natural progesterone)
Number of subjects: 20
Study: 3476985

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel followed by 1% NaF gel daily for 2 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel followed by 1% NaF gel daily for 6 weeks supplemented twice with 8% SnF2 solution
Number of subjects: 0
Study: 29715520

Group type: EXPERIMENTAL
Intervention: Opioid medications
Number of subjects: 34

Group type: COMPARATOR
Intervention: Nonopioid medications
Number of subjects: 34
Study: 27237059

Group type: EXPERIMENTAL
Intervention: Proton irradiation
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Carbon ion irradiation
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Proton and carbon ion irradiation
Number of subjects: 92
Study: 25509731

Group type: EXPERIMENTAL
Intervention: Dog-days moxibustion
Number of subjects: 72

Group type: COMPARATOR
Intervention: Regular-day moxibustion
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both groups (Dog-days and Regular-day moxibustion)
Number of subjects: 72
Study: 22421490

Group type: EXPERIMENTAL
Intervention: Web-based microsurgical curriculum
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no online resource)
Number of subjects: 17
Study: 19968674

Group type: EXPERIMENTAL
Intervention: Lavender scent
Number of subjects: 340

Group type: COMPARATOR
Intervention: No odor (Control)
Number of subjects: 340
Study: 18701540

Group type: EXPERIMENTAL
Intervention: Static resting splints plus standardized occupational therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standardized occupational therapy alone
Number of subjects: 120
Study: 15808245

Group type: EXPERIMENTAL
Intervention: Strontium plaque brachytherapy (Sr90) using plaque I (8 mm diameter, 15 Gy dose in 54 minutes)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Strontium plaque brachytherapy (Sr90) using plaque II (4 mm diameter, 12.6 Gy dose in 11 minutes)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (observation without treatment)
Number of subjects: 86
Study: 14650694

Group type: EXPERIMENTAL
Intervention: Equation instruction group
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Subgoal instruction group
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study: 10791612

Group type: EXPERIMENTAL
Intervention: Adapted health care program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 8676527

Group type: EXPERIMENTAL
Intervention: Mixed micelles (bile-salt lecithin micelles)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11188601

Group type: EXPERIMENTAL
Intervention: Shoulder Pain and Disability Index (SPADI)
Number of subjects: 37
Study: 6365467

Group type: EXPERIMENTAL
Intervention: Bemetizide (25 mg) + Triamterene (50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclopenthiazide (0.25 mg) + Potassium Chloride (600 mg)
Number of subjects: 0
Study: 30807430

Group type: EXPERIMENTAL
Intervention: Multimodal pain regimen
Number of subjects: 68
Study: 27821627

Group type: EXPERIMENTAL
Intervention: Rituximab with standard therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 34
Study: 25817576

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy with Defibrillator (CRT-D)
Number of subjects: 1250

Group type: COMPARATOR
Intervention: Implantable Cardioverter-Defibrillator (ICD)
Number of subjects: 1250
Study: 24506289

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 150 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 300 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22382410

Group type: EXPERIMENTAL
Intervention: Physical masking by spray-coating famotidine with ethyl cellulose
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Organoleptic masking with added sweetener and flavor
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combination of both taste-masking methods
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo ODTs
Number of subjects: 31
Study: 19302453

Group type: EXPERIMENTAL
Intervention: Individualized pre-operative blood saving protocol (including strategies such as oral iron therapy, intravenous iron therapy, recombinant human erythropoietin alpha with i.v. iron, pre-operative autologous donation plus oral iron)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Pre-operative autologous donation (PAD)
Number of subjects: 305

Group type: COMPARATOR
Intervention: RBC transfusion
Number of subjects: 305
Study: 17967591

Group type: EXPERIMENTAL
Intervention: Enoximone (50 mg or 75 mg tid for 1 week, then reduced to 25 mg or 50 mg tid)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Enoximone
Number of subjects: 201
Study: 16335169

Group type: EXPERIMENTAL
Intervention: Crown-retained FPDs cemented with glass ionomer (n = 20) or resin composite (n = 16)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Inlay-retained FPDs cemented with resin composite (n = 45)
Number of subjects: 68
Study: 12144231

Group type: EXPERIMENTAL
Intervention: Next-generation gray Transitions Lenses
Number of subjects: 52

Group type: COMPARATOR
Intervention: Clear lenses
Number of subjects: 52

Group type: COMPARATOR
Intervention: Study purple-colored photochromic lens
Number of subjects: 52
Study: 10445717

Group type: EXPERIMENTAL
Intervention: Multipass technique
Number of subjects: 95

Group type: COMPARATOR
Intervention: Single pass technique
Number of subjects: 95
Study: 8526266

Group type: EXPERIMENTAL
Intervention: Training program involving viewing videotaped scenes where knee injuries occurred
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group (staff from 22 ski areas not exposed to the training)
Number of subjects: 179
Study: 1969066

Group type: EXPERIMENTAL
Intervention: Phosphate supplementation (50 mg per day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no phosphate supplementation)
Number of subjects: 0
Study: 154921

Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide
Number of subjects: 22

Group type: COMPARATOR
Intervention: Flumethasone pivalate
Number of subjects: 22
Study: 30399024

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D (2000 IU/day)
Number of subjects: 703
Study: 28218661

Group type: EXPERIMENTAL
Intervention: LZComplex3
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 25879974

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 23990341

Group type: EXPERIMENTAL
Intervention: Daptomycin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Comparator (pooled intravenous standard therapies: semi-synthetic penicillin or vancomycin)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Semi-synthetic penicillin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 120
Study: 21375959

Group type: EXPERIMENTAL
Intervention: Low-dose ultrasound (0.5 W/cm2) delivered at 1 MHz, pulsed pattern of 1:4, applied to periulcer skin weekly for up to 12 weeks alongside standard care.
Number of subjects: 337

Group type: COMPARATOR
Intervention: Standard care (low‐adherent dressings and compression therapy).
Number of subjects: 337
Study: 19926050

Group type: EXPERIMENTAL
Intervention: Clopidogrel 150 mg once daily for 1 week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard maintenance dosage clopidogrel (75 mg)
Number of subjects: 40
Study: 17302062

Group type: EXPERIMENTAL
Intervention: Prunellae Oral Liquid (POL) based on classical therapy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Classical therapy alone
Number of subjects: 98

Group type: COMPARATOR
Intervention: Normal control (20 healthy subjects)
Number of subjects: 98
Study: 15566594

Group type: EXPERIMENTAL
Intervention: lornoxicam (8 mg administered intravenously every 12 hours for six doses)
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 11879377

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Healing situation
Number of subjects: 0
Study: 9928916

Group type: EXPERIMENTAL
Intervention: Paroxetine (30 mg/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 8310990

Group type: EXPERIMENTAL
Intervention: High-fiber diet (HFD)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Low-fiber diet (LFD)
Number of subjects: 8
Study: 2525023

Group type: EXPERIMENTAL
Intervention: Combined reflex-therapy (including manipulations, neural therapy, and acupuncture)
Number of subjects: 1167

Group type: COMPARATOR
Intervention: Usual ambulant medicamentous physiotherapeutic treatment
Number of subjects: 1167
Study: 132779

Group type: EXPERIMENTAL
Intervention: Desoximetasone 0.25% (Ibaril)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fluocinolone acetonide 0.025% cream
Number of subjects: 50
Study: 31446845

Group type: EXPERIMENTAL
Intervention: Optimised cardiopulmonary bypass strategy (closed Cortiva® heparin‐coated circuit, low systemic heparinisation, intraoperative cell salvage)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Balance® coated open circuit, full systemic heparinisation, conventional cardiotomy suction (control group)
Number of subjects: 60
Study: 30948692

Group type: EXPERIMENTAL
Intervention: Folic Acid (5 mg/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 27267689

Group type: EXPERIMENTAL
Intervention: Higher dose beetroot juice (H-BT; 250 ml, n=10)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Lower dose beetroot juice (L-BT; 125 ml, n=9)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Isocaloric placebo (PLA; 250 ml, n=10)
Number of subjects: 29
Study: 25881059

Group type: EXPERIMENTAL
Intervention: SMS-based intervention for treatment adherence
Number of subjects: 39
Study: 24130255

Group type: EXPERIMENTAL
Intervention: Coaching Intervention (CI)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 73
Study: 21957667

Group type: EXPERIMENTAL
Intervention: Salovum egg yolk powder plus standard treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 40
Study: 19661012

Group type: EXPERIMENTAL
Intervention: metoprolol XL 25 mg/chlorthalidone 6.25 mg
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: metoprolol XL 50 mg/chlorthalidone 12.5 mg
Number of subjects: 130

Group type: COMPARATOR
Intervention: metoprolol XL 25 mg/HCTZ 12.5 mg
Number of subjects: 130

Group type: COMPARATOR
Intervention: metoprolol XL 50 mg/HCTZ 12.5 mg
Number of subjects: 130
Study: 16935462

Group type: EXPERIMENTAL
Intervention: L-thyroxine treatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no L-thyroxine treatment)
Number of subjects: 42
Study: 14632164

Group type: EXPERIMENTAL
Intervention: TG‐timolol
Number of subjects: 14

Group type: COMPARATOR
Intervention: timolol only
Number of subjects: 14
Study: 10711416

Group type: EXPERIMENTAL
Intervention: Fenofibrate therapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Dietary modification alone (Placebo)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study: 9176179

Group type: EXPERIMENTAL
Intervention: GH + placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GH + captopril
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GH + spironolactone
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo + placebo
Number of subjects: 8
Study: 1390955

Group type: EXPERIMENTAL
Intervention: Haloperidol or perazine (neuroleptic drugs)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Involuntary expression under emotion-eliciting interview conditions
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Voluntary expression
Number of subjects: 59

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 59
Study: 3909331

Group type: EXPERIMENTAL
Intervention: Aztreonam (1‐2 g administered intravenously three or four times daily)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Aztreonam
Number of subjects: 113

Group type: COMPARATOR
Intervention: Tobramycin (3‐5 mg/kg per day)
Number of subjects: 113
Study: 31165898

Group type: EXPERIMENTAL
Intervention: Stand Up Victoria intervention
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 231
Study: 29339395

Group type: EXPERIMENTAL
Intervention: Finafloxacin 800 mg once a day for 5 days (FINA05)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Finafloxacin 800 mg once a day for 10 days (FINA10)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Ciprofloxacin 400 mg/500 mg twice a day for 10 days (CIPRO10)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Ciprofloxacin (CIPRO10)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Finafloxacin (FINA05 and FINA10)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Finafloxacin (FINA05)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Finafloxacin (FINA10)
Number of subjects: 193
Study: 27575452

Group type: EXPERIMENTAL
Intervention: Continuous epidural infusion (CEI) with thoracic epidural levobupivacaine 0.12% plus sufentanil 0.4 µg/mL for 48 hours
Number of subjects: 51

Group type: COMPARATOR
Intervention: Wound infiltration and continuous infusion with local anesthetics plus a single morphine bolus (CWI‐M) with 10 mL levobupivacaine 0.5% and levobupivacaine 0.25% infusion for 48 hours
Number of subjects: 51
Study: 24816038

Group type: EXPERIMENTAL
Intervention: Pravastatin therapy
Number of subjects: 5244
Study: 23226717

Group type: EXPERIMENTAL
Intervention: Escalating contingency management (CM) schedule
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fixed contingency management (CM) schedule
Number of subjects: 90
Study: 20192531

Group type: EXPERIMENTAL
Intervention: Ability to represent 2 states of affairs
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Processing negation in the context of an inconsistency
Number of subjects: 186
Study: 18375319

Group type: EXPERIMENTAL
Intervention: Intracoronary nicardipine (1 mL, 0.1 mg)
Number of subjects: 2

Group type: COMPARATOR
Intervention: NaCl (1 mL)
Number of subjects: 2
Study: 11493736

Group type: EXPERIMENTAL
Intervention: G‐‐CSF plus dexamethasone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: G‐‐CSF alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dexamethasone alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 20
Study: 9561271

Group type: EXPERIMENTAL
Intervention: Antiadhesion device, a thin, filmy membrane composed of two organic substances that are resorbed by the body, inserted intraoperatively between apposing tissue surfaces.
Number of subjects: 0
Study: 7827630

Group type: EXPERIMENTAL
Intervention: Therapeutic massage
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Upper body ergometry
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Microcurrent electrical stimulation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (rest after exercise)
Number of subjects: 40
Study: 3048153

Group type: EXPERIMENTAL
Intervention: Indobufen 200 mg
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 31785250

Group type: EXPERIMENTAL
Intervention: 2 mg/kg of nalbuphine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2.5 μg/kg of sufentanil
Number of subjects: 60
Study: 29952216

Group type: EXPERIMENTAL
Intervention: ENABLE CHF-PC intervention (in-person palliative care assessment, weekly telehealth coaching sessions, monthly follow-up)
Number of subjects: 8
Study: 28384315

Group type: EXPERIMENTAL
Intervention: Imagine-self strategy
Number of subjects: 63

Group type: COMPARATOR
Intervention: Imagine-other strategy
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study: 26043228

Group type: EXPERIMENTAL
Intervention: GLP-1 RA liraglutide (1.2 mg/d) for 52 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (no GLP-1 RA treatment)
Number of subjects: 37
Study: 23434881

Group type: EXPERIMENTAL
Intervention: Studying a misspelling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testing spelling recognition in an old context
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Words studied misspelled
Number of subjects: 0
Study: 21641776

Group type: EXPERIMENTAL
Intervention: Adjunctive armodafinil (150 mg/d)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19621342

Group type: EXPERIMENTAL
Intervention: Discharge software
Number of subjects: 631

Group type: COMPARATOR
Intervention: Usual care, handwritten discharge
Number of subjects: 631